Drug interactions and protease inhibitor therapy in the treatment of HIV/AIDS
Article Abstract:
Protease inhibitor therapy has become very important in treatment of HIV/AIDS. Protease inhibitors undergo significant oxidative liver metabolism involving the Cytochrome P-450 (CYP450) enzyme system. They are therefore substrates, inhibitors and/or inducers of CYP450. When protease inhibitors are used with certain other drugs that are CYP450-dependent, they may change pharmacokinetics and cause changes in bioavailability. That can lead to changed clinical effect, drug interaction. The most interactive of the 4 licensed protease inhibitors is ritonavir, the least interactive saquinavir.
Publication Name: The Nurse Practitioner
Subject: Health
ISSN: 0361-1817
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Protease inhibitors
Article Abstract:
A category of drugs that interfere with the HIV life cycle called protease inhibitors may prove to have a significant impact on controlling this infection. These drugs include ritonavir, saquinavir, and indinavir. They appear to be most effective when taken in combination with other retroviral therapies. They may, however, be ineffective or harmful if taken with certain other drugs or not taken as directed. Monthly combination therapy may cost between $800 and $900.
Publication Name: The Nurse Practitioner
Subject: Health
ISSN: 0361-1817
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
News from the 5th Conference on Retroviruses and Opportunistic Infections
Article Abstract:
Highly active antiretroviral therapy (HAART) has changed some aspects of HIV infection for the better. Notable changes include fewer opportunistic infections, lower mortality rates, and altered costs of medical care. For example, hospitalization costs decreased while medication costs soared. HAART may build up the overall immune strength of patients.
Publication Name: The Nurse Practitioner
Subject: Health
ISSN: 0361-1817
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Intrasphincteric botulinum toxin for the treatment of achalasia. Treatment of achalasia - from whalebone to botulinum toxin
- Abstracts: Comparison of 1% and 2.5% selenium sulfide in the treatment of tinea capitis. Asymptomatic Dermatophyte Carriers in the Households of Children With Tinea Capitis
- Abstracts: Changes in nutrition among residents and refugees in Sarajevo during the war. Nutrition in pre-war Sarajevo
- Abstracts: A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis
- Abstracts: Thrombocytopenia in pregnant women who use cocaine. Children in the process of becoming. Preoperative anxiety in children: predictors and outcomes